Frontal lobe (35.3%) was the preferred location for tumors with both methylated and unmethylated MGMT promoter.This may be due to the fact that frontal lobe being the largest is also the commonest site for gliomas. The gene discussed is MGMT; the disease is central nervous system cancer.